D Scott Edwards

Title: D Scott Edwards: Innovator in Pharmaceutical Chemistry

Introduction

D Scott Edwards is a prominent inventor based in Bedford, MA (US), known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, he has made remarkable advancements in the field, particularly in the development of novel compounds for medical applications.

Latest Patents

Among his latest patents, one notable invention is the "Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives." This application focuses on 2-amino-4-(substituted amino)phenyl carbamate derivatives, or their pharmaceutically acceptable salts or solvates, which serve as KCNQ2/3 potassium channel modulators. The methods of their uses are also explored in this patent. Another significant patent is for "Fluorinated integrin antagonists," which relates to fluorinated compounds and methods for synthesizing these compounds. This invention also includes pharmaceutical compositions containing these fluorinated compounds, aimed at treating conditions such as macular degeneration, diabetic retinopathy, and macular edema.

Career Highlights

D Scott Edwards has worked with several notable companies in the pharmaceutical sector, including Scifluor Life Sciences, Inc. and Ocuterra Therapeutics, Inc. His work has been instrumental in advancing the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Edwards has collaborated with talented individuals, including Takeru Furuya and Mark E Duggan. These collaborations have contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

D Scott Edwards stands out as a key figure in pharmaceutical innovation, with a strong portfolio of patents that reflect his expertise and dedication to improving healthcare solutions. His contributions continue to impact the field positively.